• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Communication, Education, and Radiological Programs (OCER) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Information is current as of September 30, 2013

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetPercent
Oct 201285100
Nov 20128594
Dec 201285100
Jan 20138594
Feb 201385100
Mar 20138598
Apr 20138576
May 201385100
Jun 20138595
Jul 201385100
Aug 201385100
Sep 20138589

FY 2013 Overall: 95%

Number of OCER intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2012N/A45
Nov 2012N/A31
Dec 2012N/A51
Jan 2013N/A45
Feb 2013N/A24
Mar 2013N/A61
Apr 2013N/A57
May 2013N/A52
Jun 2013N/A52
Jul 2013N/A27
Aug 2013N/A69
Sep 2013N/A39

FY 2013 Total: 553

Total number of OCER intra- and inter-Office eConsults completed during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2012N/A45
Nov 2012N/A33
Dec 2012N/A51
Jan 2013N/A48
Feb 2013N/A24
Mar 2013N/A62
Apr 2013N/A75
May 2013N/A52
Jun 2013N/A55
Jul 2013N/A27
Aug 2013N/A69
Sep 2013N/A44

FY 2013 Total: 585

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.